U.S. MARKETS FOR INFECTION CONTROL AND BIOSAFETY PRODUCTS

261 Pages | 76 Exhibits | 2003 Analysis | Forecasts Through 2010

OVERVIEW:
Infectious diseases are the leading cause of death worldwide and the third-leading cause of death in the United States. Infectious diseases can affect any body system, be classified as acute or chronic, occur with or without fever, strike any age group, and exist concurrently with one another. Bacteria, parasites, and viruses are among the organisms that cause infectious diseases, many of which have only recently been identified.

Although handwashing, medical waste disposal, and the use of vaccines have greatly reduced the incidence of infectious diseases in developed countries, undeveloped countries, which have reduced access to vaccines and a lack of widespread education regarding infection control practices, are experiencing devastating numbers of infectious diseases that have been nearly eradicated in other parts of the world.

This report by Medtech Insight presents a detailed overview of infectious diseases, infection control and prevention, and the infection control and diagnostic products market. Included in this report are 14 company profiles and market analyses of infection control and biosafety products such as injection devices and related products; handwashing, surgery preparations, and germicides; sterilization equipment, services, and supplies; and wound closure devices.

TABLE OF CONTENTS:

EXECUTIVE SUMMARY

i.      Report Methodology

ii.     Overview of Infectious Organisms and Diseases

iii.    Infectious Diseases Demographics and National Guidelines for Control

iv.    Nosocomial and Community-Acquired Infections and Prevention Strategies

v.     Injection Devices and Related Products

vi.    Handwashes, Surgery Preparations, and Germicides

vii.   Sterilization Equipment, Services, and Supplies

viii.   Wound Closure Devices

ix.    Combined Market Analysis

 

1. OVERVIEW OF INFECTIOUS ORGANISMS AND DISEASES

1.1 Bacterial Infections

1.1.1     Anthrax

1.1.2     Botulism

1.1.3     Brucellosis

1.1.4     Cholera

1.1.5     Diphtheria

1.1.6     Diseases Associated with Haemophilus spp.

1.1.7     Diseases Associated with Mycobacteria spp.

1.1.8     Diseases Associated with Pseudomonas spp.

1.1.9     Diseases Associated with Staphylococcus spp.

1.1.10    Diseases Associated with Streptococcus spp.

1.1.11    Escherichia coli Infection

1.1.12    Gonorrhea/Meningitis

1.1.13    Legionnaires' Disease

1.1.14    Listeriosis

1.1.15    Lyme Disease

1.1.16    Nocardiosis

1.1.17    Salmonella

1.1.18    Tularemia

1.1.19    Yersiniosis

1.2 Parasitic Infections

1.2.1     Giardiasis

1.2.2     Roundworm

1.2.2.1     Ascariasis

1.2.2.2     Hookworm

1.2.2.3     Pinworm

1.2.2.4     Whipworm

1.2.3     Tapeworm

1.3 Proteinaceous Infections

1.3.1     Bovine Spongiform Encephalopathy

1.3.1.1     New-Variant Creutzfeldt-Jakob Disease

1.4 Viral Infections

1.4.1     Dysentery

1.4.2     Encephalitis

1.4.3     Hemorrhagic Fever

1.4.4     Hepatitis

1.4.5     Herpes Simplex

1.4.6     Herpes Zoster

1.4.7     Human Immunodeficiency Virus

1.4.8     Human Papillomavirus

1.4.9     Influenza

1.4.10    Measles

1.4.11    Mononucleosis

1.4.12    Mumps

1.4.13    Respiratory Syncytial Virus

1.4.14    Parvovirus

1.4.15    Poliomyelitis

1.4.16    Protozoa

1.4.17    Varicella

1.4.18    Variola

1.5 Diagnosis

1.5.1     Bacterial Infection Diagnosis

1.5.1.1     Cultures

1.6 Parasitic Infection Diagnosis

1.6.1     Serology

1.7 Viral Infection Diagnosis

1.8 Other Diagnostic Tests

1.8.1     Imaging

1.8.2     Invasive Tests

1.8.3     Smears

 

2. INFECTIOUS DISEASES DEMOGRAPHICS AND NATIONAL GUIDELINES FOR CONTROL

2.1 Demographics Overview

2.1.1     High Risk Populations

2.1.1.1     Acute Healthcare

2.1.1.1.1  Patients

2.1.1.1.2  Healthcare Workers

2.1.1.2     Long-Term Healthcare

2.1.1.2.1  Patients

2.1.1.2.2  Healthcare Workers

2.1.2     Types of Acquired Infections

2.1.2.1     Airborne Pathogens

2.1.2.2     Bloodborne Pathogens

2.1.3     Impact of Managed Care

2.1.4     Drug-Resistance

2.1.4.1     Methicillin-Resistant Staphylococcus Aureus

2.1.4.2     Vancomycin-Resistant Enterococcus

2.1.4.3     Types of Microbes and Viruses

2.1.4.4     Impact on Cost of Care

2.1.5     Technological Developments

2.2 National Guidelines Overview

2.2.1     American Association of Perioperative Registered Nurses

2.2.2     American Nurses Association

2.2.3     American Society for Healthcare Central Service Professionals

2.2.4     Association for the Advancement of Medical Instrumentation

2.2.5     Association for Professionals in Infection Control and Epidemiology

2.2.6     Centers for Disease Control and Prevention

2.2.6.1     National Institute for Occupational Safety and Health

2.2.7     International Association of Healthcare Central Service Material Management

2.2.8     Joint Commission on Accreditation of Healthcare Organizations

2.2.9     Occupational Safety and Health Administration

2.2.10    Service Employees International Union

2.2.11    Society for Healthcare Epidemiology of America

2.2.12    United States Food and Drug Administration

 

3. NOSOCOMIAL AND COMMUNITY-ACQUIRED INFECTIONS AND PREVENTION STRATEGIES

3.1 Overview

3.2 National Nosocomial Infections Surveillance

3.2.1     High-Risk Delivery Areas

3.2.1.1     Intensive Care Unit Infection Rates

3.2.1.1.1  Bloodstream Infections

3.2.1.1.2  Respiratory Tract Infections

3.2.1.1.3  Surgical Site Infections

3.2.1.1.4  Urinary Tract Infections

3.2.1.2     Device-Related Infections

3.2.1.3     Hospital Practices-Related Infections

3.2.2     Mortality Rates

3.2.3     Related Costs

3.2.4     Prevention Strategies

3.3 Nosocomial Infection Prevention

3.3.1     Skin Preparation

3.3.1.1     Handwashing

3.3.1.2     Perioperative Patient Skin Preparation

3.3.1.3     Surgical Scrubbing

3.3.2     Safety Needles

3.3.3     Infection-Resistant Products

3.3.4     Cleaning, Disinfection, and Sterilization

3.3.4.1     Cleaning

3.3.4.1.1  Scrubbing by Hand

3.3.4.1.2  Ultrasonic Cleaning

3.3.4.2     Disinfection

3.3.4.2.1  Liquid Chemicals

3.3.4.3     Sterilization

3.3.4.3.1  Autoclaving

3.3.4.3.2  Ethylene Oxide

3.3.4.3.3  Flash

3.3.4.3.4  Gamma Radiation

3.3.4.3.5  Hydrogen Peroxide

3.3.4.3.6  Microwave

3.3.4.3.7  Ozone

3.3.4.3.8  Peracetic Acid

3.3.5     Antimicrobial Barriers

3.3.6     Handling and Disposal of Medical Waste

3.3.6.1     Products and Technology

3.3.6.1.1  Autoclaving

3.3.6.1.2  Chemical Disposal

3.3.6.1.3  Incineration

3.3.6.1.4  Microwaving

3.3.6.1.5  Plasma Pyrolysis

3.3.6.2     Market Analysis

3.3.7     Ventilation Systems Management

3.3.7.1     Air Filtration Systems

3.3.7.1.1  Products and Technologies

3.3.7.1.2  Market Forecast

3.3.7.2     Indoor Air Quality Monitoring Systems

3.3.7.2.1  Products and Technologies

3.3.8     Single-Patient-Use versus Reusable Medical Devices

3.3.8.1     Multiple Use of Single-Patient-Use Medical Devices

3.3.8.1.1  Products and Technologies

3.3.8.1.2  Market Analysis

 

4. INJECTION DEVICES AND RELATED PRODUCTS

4.1 Overview

4.2 Skin Puncture Devices

4.2.1     Regulations and Guidelines

4.2.1.1     Federal Legislation

4.2.1.2     State Legislation

4.2.2     Needlestick Prevention

4.2.3     Products and Technologies

4.2.4     Market Analysis

4.2.4.1     Disposable Needles and Syringes

4.2.4.1.1  Competitive Analysis

4.2.4.2     Safety Needles and Syringes

4.2.4.2.1  Competitive Analysis

4.2.4.2.2  Retractable Syringes

4.2.4.2.3  Other Products

4.2.4.3     Phlebotomy and Venipuncture Needle Devices

4.3 Non-Skin Puncture Devices

4.3.1     Products and Technologies

4.3.2     Market Analysis

4.3.3     Competitive Analysis

4.4 Alternatives to Traditional Injection Systems

4.4.1     Products and Technologies

4.4.1.1     Auto-Injectors

4.4.1.2     Inhalation Drug Delivery

4.4.1.3     Iontophoresis

4.4.1.4     Powder Injection

4.4.1.5     Transdermal Drug Delivery

4.5 Sharps Disposal Products

4.5.1     Regulations and Guidelines

4.5.2     Products and Technologies

4.5.3     Market Analysis

4.6 Combined Market Forecast

 

5. HANDWASHES, PERIOPERATIVE SKIN PREPARATIONS, AND GERMICIDES

5.1 Handwashes and Perioperative Skin Preparations

5.1.1     Handwashes and Surgical Scrubs

5.1.1.1     Guidelines

5.1.1.2     Compliance

5.1.1.3     Products and Technologies

5.1.1.3.1  Hygienic Handwashes

5.1.1.3.2  Surgical Scrubs

5.1.1.4     Market Analysis

5.1.2     Perioperative Skin Preparations

5.1.2.1     Products

5.1.2.2     Market Analysis

5.1.3     Combined Market Analysis

5.2 Disinfectants and Germicides

5.2.1     Products

5.2.1.1     High-Level Disinfectants

5.2.1.1.1  Market Analysis

5.2.1.2     Low-Level Disinfectants

5.2.1.2.1  Market Analysis

5.2.2     Combined Market Analysis

5.3 Combined Market Analysis

 

6. STERILIZATION EQUIPMENT, SERVICES, AND SUPPLIES

6.1 Sterility Assurance Level

6.2 Technology

6.3 Equipment

6.3.1     Sterilizers

6.3.1.1     Regulations and Guidelines

6.3.1.2     Products and Technology

6.3.1.3     Market Analysis

6.4 Services

6.4.1     Contract Sterilization

6.4.1.1     Market Analysis

6.5 Supplies

6.5.1     Products and Technology

6.5.2     Market Analysis

6.6 Combined Market Analysis

 

7. WOUND CLOSURE DEVICES

7.1 Traditional Wound Closure

7.1.1     Products and Technologies

7.1.1.1     Staples

7.1.1.1.1  Market Analysis

7.1.1.1.2  Competitive Analysis

7.1.1.2     Sutures

7.1.1.2.1  Market Analysis

7.1.1.2.2  Competitive Analysis

7.1.1.3     Wound Closure Strips

7.1.1.3.1  Market Analysis

7.1.1.3.2  Competitive Analysis

7.2 Emerging Technologies

7.2.1     Automated Suturing Devices

7.2.1.1     Market Analysis

7.2.1.2     Competitive Analysis

7.2.2     Energy-Based Closure Devices

7.2.2.1     Market Analysis

7.2.2.2     Competitive Analysis

7.2.3     Surgical Sealants and Glues

7.2.3.1     Market Analysis

7.2.3.2     Competitive Analysis

7.3 Combined Market Analysis

 

8. COMPANY PROFILES

8.1   3M Company

8.2   Abbott Laboratories, Inc.

8.3   Axya Medical, Inc.

8.4   Baxter International, Inc.

8.5   B. Braun Melsungen AG

8.6   Becton, Dickinson and Company

8.7   Cohesion Technologies Corporation/Angiotech Pharmaceuticals, Inc.

8.8   Johnson & Johnson

8.9   Kimberly-Clark, Inc.

8.10 Portex, Inc./Smiths Group PLC

8.11 Purdue Frederick Company/Purdue Pharma LP

8.12 Stericycle, Inc.

8.13 STERIS Corporation

8.14 Tyco Healthcare, Inc./Tyco International LTD

 

APPENDIX:  COMPANY LISTING

 

LIST OF EXHIBITS

 

Exhibit ES-1:  Injection Devices and Related Products, Market Forecast, 2001-2010

Exhibit ES-2:  Handwashes, Perioperative Skin Preparations, and Germicides, Market Forecast, 2001-2010

Exhibit ES-3:  Sterilization Equipment, Services, and Supplies, Market Forecast, 2001-2010

Exhibit ES-4:  Wound Closure Devices, Market Forecast, 2001-2010

Exhibit ES-5:  Infection Control and Biosafety Products, Combined Market Forecast,  2001-2010

 

Exhibit 1-1:    Selected Pathogenic Microbes and Resulting Diseases

Exhibit 1-2:    Selected Diseases, Causes of Emergence, and Modes of Transmission

Exhibit 1-3:    Selected Biological Diseases and Agents, by Category

Exhibit 1-4:    Selected Herpes Viruses

Exhibit 1-5:    Selected Bacterial Infections, Symptoms, and Diagnostic Tests

Exhibit 1-6:    Selected Parasitic Infections, Symptoms, and Diagnostic Tests

Exhibit 1-7:    Selected Viral Infections, Symptoms, and Diagnostic Tests

 

Exhibit 2-1:    Population Distribution, by Age, 1990, 1995, 2000, 2005, 2010, and 2020

Exhibit 2-2:    Length-of-Stay in Nonfederal, Short-Stay Hospitals, 1970, 1985, 1990, 1995, and 1998

Exhibit 2-3:    2001, Selected Occupationally Acquired Infections, by Area of Employment

Exhibit 2-4:    2001, Selected Occupationally Acquired Infections, by Mode of Disease Transmission

Exhibit 2-5:    1999, Selected Antimicrobial-Resistant Pathogens in Intensive Care Unit Patients

Exhibit 2-6:    1998, Selected Drug-Resistant Infectious Agents, by Country or Region

 

Exhibit 3-1:    Device-Associated Infection Rates, by Type of Device, 1995-2002

Exhibit 3-2:    Nosocomial Infection Prevention Strategies

Exhibit 3-3:    Advantages and Disadvantages of Selected Sterilization Technologies

Exhibit 3-4:    Medical Waste Disposal Products and Services, Market Forecast, 2001-2010

Exhibit 3-5:    Occupational Safety and Health Administration Air Quality Guidelines

Exhibit 3-6:    2003, Selected Air Filtration Products

Exhibit 3-7:    Portable Air Filtration Products, Market Forecast, 2001-2010

Exhibit 3-8:    2003, Selected Indoor Air Quality Monitoring Systems

 

Exhibit 4-1:    2003, Needlestick Safety Devices, by Type

Exhibit 4-2:    Skin Puncture Devices, Market Forecast, 2001-2010

Exhibit 4-3:    2001, Standard Disposable Needles and Syringes Market, Share by Supplier

Exhibit 4-4:    2003, Selected Safety Needles and Syringes

Exhibit 4-5:    2001, Safety Needles and Syringes Market, Share by Supplier

Exhibit 4-6:    Non-Skin Puncture Devices, Market Forecast, 2001-2010

Exhibit 4-7:    2001, Non-Skin Puncture Devices Market, Share by Supplier

Exhibit 4-8:    Occupational Safety and Health Administration Criteria for Sharps Disposable Container Safety

Exhibit 4-9:    Sharps Disposal Containers, Market Forecast, 2001-2010

Exhibit 4-10:  Injection Devices and Related Products, Combined Market Forecast, 2001-2010

 

Exhibit 5-1:    Healthcare Hand Antisepsis Product Categories

Exhibit 5-2:    2003, Selected Antimicrobials Used for Hand Antisepsis

Exhibit 5-3:    2003, Selected Handwashing Products

Exhibit 5-4:    2003, Selected Hand Antisepsis Scrub Products

Exhibit 5-5:    Handwashes and Surgical Scrubs, Market Forecast, 2001-2010

Exhibit 5-6:    2003, Selected Perioperative Skin Preparation Products

Exhibit 5-7:    Perioperative Skin Preparations, Market Forecast, 2001-2010

Exhibit 5-8:    Handwashes and Perioperative Skin Preparations, Combined Market Forecast, 2001-2010

Exhibit 5-9:    2001, Handwashes and Perioperative Skin Preparations Market, Share by Supplier

Exhibit 5-10:  2003, Selected High-Level Disinfectants

Exhibit 5-11:  High-Level Disinfectants, Market Forecast, 2001-2010

Exhibit 5-12:  2003, Selected Low-Level Disinfectants

Exhibit 5-13:  Low-Level Disinfectants, Market Forecast, 2001-2010

Exhibit 5-14:  Disinfectants and Germicides, Combined Market Forecast, 2001-2010

Exhibit 5-15:  Handwashes, Perioperative Skin Preparations, and Germicides, Combined Market Forecast, 2001-2010

 

Exhibit 6-1:    2003, Comparison of Selected Sterilization Methods

Exhibit 6-2:    2003, Selected Sterilization Products

Exhibit 6-3:    Sterilization Equipment, Market Forecast, 2001-2010

Exhibit 6-4:    Contract Sterilization Services, Market Forecast, 2001-2010

Exhibit 6-5:    Sterilization Supplies, Market Forecast, 2001-2010

Exhibit 6-6:    Sterilization Equipment, Services, and Supplies, Market Forecast, 2001-2010

Exhibit 6-7:    2001, Sterilization Equipment, Services, and Supplies Market, Share by Supplier

 

Exhibit 7-1:    Skin Layers and Supporting Structures

Exhibit 7-2:    Major Wound Types, by Causation

Exhibit 7-3:    2001, Inpatient and Outpatient Surgery, Procedure Volumes

Exhibit 7-4:    2001, Incidence of Major Wound Types

Exhibit 7-5:    Wound Stapling Products, Market Forecast, 2001-2010

 

Exhibit 7-6:    2001, Surgical Staplers Market, Share by Supplier

Exhibit 7-7:    Sutures, Market Forecast, 2001-2010

Exhibit 7-8:    2003, Selected Sutures

Exhibit 7-9:    Wound Closure Strips, Market Forecast, 2001-2010

Exhibit 7-10:  2001, Wound Closure Strips Market, Share by Supplier

Exhibit 7-11:  Automated Suturing Devices, Market Forecast, 2001-2010

Exhibit 7-12:  2001, Automated Suturing Devices Market, Share by Supplier

Exhibit 7-13:  Energy-Based Closure Devices, Market Forecast, 2001-2010

Exhibit 7-14:  2001, Energy-Based Closure Devices Market, Share by Supplier

Exhibit 7-15:  Modes of Action for Surgical Sealants and Glues

Exhibit 7-16:  Surgical Sealants and Glues, Market Forecast, 2001-2010

Exhibit 7-17:  2001, Surgical Sealants and Glues Market, Share by Supplier

Exhibit 7-18:  Wound Closure Devices, Combined Market Forecast, 2001-2010



COMPANIES COVERED:

  1. 3M Company
  2. Abbott Laboratories, Inc.
  3. Axya Medical, Inc.
  4. Baxter International, Inc.
  5. B. Braun Melsungen AG
  6. Becton, Dickinson and Company
  7. Cohesion Technologies Corporation/Angiotech Pharmaceuticals, Inc.
  8. Johnson & Johnson
  9. Kimberly-Clark, Inc.
  10. Portex, Inc./Smiths Group PLC
  11. Purdue Frederick Company/Purdue Pharma LP
  12. Stericycle, Inc.
  13. STERIS Corporation
  14. Tyco Healthcare, Inc./Tyco International LTD
Contact Us

Need help finding medtech research? Let us help you!